Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf M Huber

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Pneumologie (Stuttgart, Germany)|December 13, 2023
[Early detection of lung cancer - current status and implementation scenarios]Rudolf M Huber
Current Opinion in Oncology|October 22, 2023
Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancerRudolf M Huber
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Is lung cancer in never-smokers a different disease?--Back to the figuresRudolf M Huber
Current Opinion in Oncology|November 11, 2024
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancerRudolf M Huber, Diego Kauffmann-Guerrero
Onkologie|September 16, 2006
[Pillnitz interdisciplinary discussion--summary]Ulrich Gatzemeier, Frank Griesinger, Rudolf M Huber
The European Respiratory Journal|February 23, 2013
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancerRudolf M Huber, Martin Reck, Michael Thomas
Onkologie|June 9, 2012
[Quality assurance]Michael Flentje, Hans Hoffmann, Rudolf M Huber
Onkologie|June 17, 2011
[Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]Frank Griesinger, Rudolf M Huber, Michael Thomas
Drugs|November 23, 2020
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Pneumologie (Stuttgart, Germany)|December 13, 2023
[Early detection of lung cancer - current status and implementation scenarios]Rudolf M Huber
Current Opinion in Oncology|October 22, 2023
Neoadjuvant therapy with immune checkpoint inhibitors in operable nonsmall cell lung cancerRudolf M Huber
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Is lung cancer in never-smokers a different disease?--Back to the figuresRudolf M Huber
Current Opinion in Oncology|November 11, 2024
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancerRudolf M Huber, Diego Kauffmann-Guerrero
Onkologie|September 16, 2006
[Pillnitz interdisciplinary discussion--summary]Ulrich Gatzemeier, Frank Griesinger, Rudolf M Huber
The European Respiratory Journal|February 23, 2013
Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancerRudolf M Huber, Martin Reck, Michael Thomas
Onkologie|June 9, 2012
[Quality assurance]Michael Flentje, Hans Hoffmann, Rudolf M Huber
Onkologie|June 17, 2011
[Clinic for Radiation Therapy and Internal Medicine Oncology, Pius-Hospital Oldenburg, Germany]Frank Griesinger, Rudolf M Huber, Michael Thomas
Drugs|November 23, 2020
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Pageof 11